Annelien Van Dalem

机构：Universitair Ziekenhuis Brussel · ORCID：0000-0003-2304-5298

发表论文 29 篇 · 总被引 362 次 · h-index 11

代表论文

• Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and HLA-DQ Genotype in a Registry-Based Group of Children and Adults With a First-Degree Relative With Type 1 Diabetes (2017 · Diabetes Care · 被引 67)
• Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients (2012 · Clinical & Experimental Immunology · 被引 51)
• In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam (2018 · Antimicrobial Agents and Chemotherapy · 被引 46)
• Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes (2015 · Diabetes Care · 被引 30)
• HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients (2012 · Diabetes · 被引 27)
• Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes (2015 · Diabetologia · 被引 26)